Stock Market & Financial Investment News

News Breaks January 15, 2013 07:45 EDT CELG Celgene price target raised to $112 from $100 at Brean Capital Brean Capital raised its price target on Celgene ahead of Q4 results. The firm expects earnings to be in-line with Street expectations but sees compounded earnings over the next three years to increase 20% based on the potential of the company's hematology/oncology franchise. Shares are Buy rated. News For CELG From The Last 14 Days Check below for free stories on CELG the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 09:51 EDT CELG Celgene management to meet with JPMorgan Meetings to be held in Boston on May 22-23 hosted by JPMorgan. May 17, 2013 05:51 EDT CELG Stocks with implied volatility movement; CBST CELG Subscribe for More Information May 16, 2013 11:50 EDT CELG Celgene, Gilead lower after new data published at ASCO Subscribe for More Information May 7, 2013 07:18 EDT CELG Barclays has increased confidence in Celgene's re-filing of Revlimid Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.